Table 2. Final diagnoses of the lesions that were visible by radial-probe EBUS and sensitivity of the procedure.

Diagnosis	Pulmonary lesions
	Nodules		Masses
	Cases	Sensitivity	Cases	Sensitivity
	N (%)	N diagnosed (%)	N (%)	N diagnosed (%)
Malignancy	14 (51.8)	10 (71.4)	10 (83.3)	9 (90.0)
Non-small cell lung cancer	10 (37.0)	7 (70.0)	8 (66.7)	7 (87.5)
Small cell lung cancer	2 (7.4)	2 (100.0)	1 (8.3)	1 (100.0)
Adenoid cystic carcinoma	1 (3.7)	1 (100.0)
Hamartoma	1 (3.7)	0 (0.0)
Metastatic breast cancer			1 (8.3)	1 (100.0)
Tuberculosis or fungal infection	4 (14.8)	2 (50.0)
Inflammatory disease	3 (11.1)	3 (100.0)	2 (16.7)	2 (100.0)
Nonspecific benign disease	6 (22.2)	6 (100.0)
Total	27 (100.0)	20 (74.1)	12 (100.0)	11 (91.7)